Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The therapeutic and prognostic role of cuproptosis-related genes in triple negative breast cancer.

BMC bioinformatics - 31 May 2023

Shi Bingye, Zhang Wei, Wang Tao, Cui Zhenyu

Abstract excerpt

BACKGROUND: This study aimed to observe the potential impact of known cuproptosis-related genes (CRGs) on triple negative breast cancer (TNBC) development, as well as their associated molecular mechanisms, immune infiltration mechanisms and potential therapeutic agents. RESULTS: Based on the Cox Proportional Hazard Model, 11 CRGs may be especially important in TNBC development and progression (considered as the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Copper
Share to Dasatinib

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Docetaxel

Share to Mutation

Share to Prognosis

Share to Triple Negative Breast Neoplasms

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 37259036
DOI: 10.1186/s12859-023-05348-3
PMCID: PMC10234018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The therapeutic and prognostic role of cuproptosis-related genes in triple negative breast cancer.PMID 37259036Read ↗

Identification of molecular subtypes and a six-gene risk model related to cuproptosis for triple negative breast cancerSemantic proximity Read ↗

Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancerSemantic proximity Read ↗

A Signature of Cuproptosis-Related lncRNAs Predicts Prognosis and Provide Basis for Future Anti-tumor Drug Development in Breast CancerSemantic proximity Read ↗

Integrated bulk and single-cell transcriptomic analysis unveiled a novel cuproptosis-related lipid metabolism gene molecular pattern and a risk index for predicting prognosis and antitumor drug sensitivity in breast cancerSemantic proximity Read ↗

Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancerSemantic proximity Read ↗

Multi-omics analysis of Cuproptosis-Related Signature Guides the Precision Immunotherapy and Prognosis of Breast CancerSemantic proximity Read ↗

Construction of a prognostic model based on cuproptosis-related patterns for predicting survival, immune infiltration, and immunotherapy efficacy in breast cancerSemantic proximity Read ↗

Transcriptome profiling reveals cuproptosis heterogeneity in triple-negative breast cancerSemantic proximity Read ↗

Identification of Immune-related Cuproptosis Genes in the Prognosis of Thyroid CancerSemantic proximity Read ↗

Cuproptosis-associated genes and immune microenvironment characterization in breast cancer.Semantic proximity Read ↗

A Novel Prognostic Model for DLBCL Patients Based on Cuproptosis-related GenesSemantic proximity Read ↗

Construction and validation of a prognostic risk model for cuproptosis-related lncrna in breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.